Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi Biologics, Adagene Enter Strategic Development and Mfg. Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi Biologics, Adagene Enter Strategic Development and Mfg. Pact

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics and Adagene Inc., an emerging biotech company developing antibody therapeutics, entered a strategic collaboration to support supply of Adagene’s products for clinical trials under Investigational New Drug (IND) applications in both China and the U.S. Adagene has an internal pipeline of antibody therapeutics focused on difficult antigens, and therapeutic candidates with enhanced biophysical properties.  

“The strategic collaboration with WuXi Biologics will enable Adagene to focus on our core competency in the discovery of novel antibody therapeutics and by leveraging the process development and manufacturing capabilities of WuXi Biologics will accelerate Adagene’s next wave of innovative products into the clinic,” said Dr. Peter Luo, co-founder and chief executive officer of Adagene.

“We are pleased to work closely with Adagene in developing and manufacturing some urgently-needed antibody therapeutics through the world-class, high-quality biologics platform at WuXi Biologics,” said Dr. Chris Chen, chief executive officer of WuXi Biologics. “The collaboration is expected to introduce the world-class life-saving biologics to the Chinese market, and then benefit patients around the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters